Latest Prescription Drugs news
FDA Approves Inluriyo for Advanced Breast Cancer
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Opzelura for Atopic Dermatitis in Children
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
